Search results for: Generics
Filter search results
New Antimicrobial Drugs: EU Policy Options
4 October 2010
…development of new antibiotics requires understanding current disincentives. The authors identify four key sets of factors: (1) low returns in the market because of the availability of generics, the effects…
Antibacterials: Roundtable Addresses the Critical Issues
10 November 2011
…raised included the danger of stewardship being a screen for anticompetitive behavior, the need to include generics, and the possibility of a tax on newly-generic antibiotics to raise funds for…
Just Released: Health and the Use of Medicines in Wales
3 November 2011
…than elsewhere in the UK. This is explained in large part by a more rapid increase in Wales in prescribing of lower cost medicines, including generics. The report also shows…
The WHO Technical Report on the Pricing of Cancer Medicines: Missing a Central Role for Value Assessment
8 April 2019
…by volume in high-income countries) are off-patent multi-source generics (and, in the future biosimilars). Advice on the effective procurement of these products is key. Acknowledge that R&D is best incentivised…
Future UK Medicines Spending: Four Nation Analysis
31 October 2012
…and generics) were divided into primary care and secondary care markets. 2. For each market, we calculated sales for each of the four nations for 2011. 3. To project sales…
What do Pharmaceuticals Really Cost in the Long Run?
6 October 2017
…the average market price in the year generics entered the market the price was 6% lower than the LOE price. After 5 years it was 55% lower and after 10…
Health and the Use of Medicines in Primary Care in Wales
1 November 2011
…than elsewhere in the UK. This is explained in large part by a more rapid increase in Wales in prescribing of lower cost medicines, including generics. The report also shows…
Published: OHE Study Projecting UK Medicines Expenditure
30 September 2013
…new generics and biosimilars. In a comparison of results, the bottom-up approach was shown to provide richer detail about causes and distribution of costs, i.e. which therapeutic areas may consume…
Antimicrobials Resistance: A Call for Multi-disciplinary Action. How Can HTA Help?
1 October 2017
This briefing provides a detailed summary of a symposium held at the HTAi 2017 meeting in Rome. This briefing provides a detailed summary of a symposium held at the HTAi…